Literature DB >> 3119325

Retroviral expression of the human IL-2 gene in a murine T cell line results in cell growth autonomy and tumorigenicity.

G Yamada1, Y Kitamura, H Sonoda, H Harada, S Taki, R C Mulligan, H Osawa, T Diamantstein, S Yokoyama, T Taniguchi.   

Abstract

In mature T lymphocytes (T cells) the regulated expression of the genes for interleukin-2 (IL-2) and its receptor (IL-2R) constitutes an essential part in controlling the cell growth. Evidence has been provided which suggests the involvement of an aberrant function of the IL-2 system in developing T cell neoplasms, particularly the adult T cell leukemia/lymphoma (ATL). As an approach to examine the extent of the IL-2 system contribution to T cell neoplasms, we created the experimental conditions wherein both IL-2 and IL-2R are expressed constitutively in a murine T cell line. We made use of a retroviral vector to infect an IL-2-dependent CTLL-2 line and lead to the expression of human IL-2. Here, we show that the virus-infected cells not only proliferate in vitro in the absence of exogenously supplied IL-2 under certain conditions, but also develop tumors (lymphomas) in nude and syngeneic mice.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3119325      PMCID: PMC553693          DOI: 10.1002/j.1460-2075.1987.tb02563.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  36 in total

1.  Transformation of mammalian cells with genes from procaryotes and eucaryotes.

Authors:  M Wigler; R Sweet; G K Sim; B Wold; A Pellicer; E Lacy; T Maniatis; S Silverstein; R Axel
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

2.  MSA and EGF receptors on sarcoma virus transformed cells and human fibrosarcoma cells in culture.

Authors:  G J Todaro; J E De Larco; S P Nissley; M M Rechler
Journal:  Nature       Date:  1977-06-09       Impact factor: 49.962

Review 3.  Molecular analysis of the interleukin-2 system.

Authors:  T Taniguchi; H Matsui; T Fujita; M Hatakeyama; N Kashima; A Fuse; J Hamuro; C Nishi-Takaoka; G Yamada
Journal:  Immunol Rev       Date:  1986-08       Impact factor: 12.988

4.  Growth factors from murine sarcoma virus-transformed cells.

Authors:  J E de Larco; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

5.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

6.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

Review 7.  T-cell growth factor.

Authors:  K A Smith
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

8.  Autocrine secretion and malignant transformation of cells.

Authors:  M B Sporn; G J Todaro
Journal:  N Engl J Med       Date:  1980-10-09       Impact factor: 91.245

9.  Surface phenotype of Japanese adult T-cell leukemia cells characterized by monoclonal antibodies.

Authors:  T Hattori; T Uchiyama; T Toibana; K Takatsuki; H Uchino
Journal:  Blood       Date:  1981-09       Impact factor: 22.113

10.  Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor.

Authors:  J E Gootenberg; F W Ruscetti; J W Mier; A Gazdar; R C Gallo
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more
  23 in total

1.  Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.

Authors:  T Aoki; K Tashiro; S Miyatake; T Kinashi; T Nakano; Y Oda; H Kikuchi; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

2.  Transduction of an IL-2 gene into human melanoma-reactive lymphocytes results in their continued growth in the absence of exogenous IL-2 and maintenance of specific antitumor activity.

Authors:  K Liu; S A Rosenberg
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

3.  Autocrine regulation of T-lymphocyte proliferation: differential induction of IL-2 and IL-2 receptor.

Authors:  D A Cantrell; M K Collins; M J Crumpton
Journal:  Immunology       Date:  1988-11       Impact factor: 7.397

4.  Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus.

Authors:  S J Russell; A Brandenburger; C L Flemming; M K Collins; J Rommelaere
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

5.  Advantages of a unique DNA-based vaccine in comparison to paclitaxel in treatment of an established intracerebral breast cancer in mice.

Authors:  Terry Lichtor; Roberta P Glick; Henry Lin; Amla Chopra; Insug O-Sullivan; Edward P Cohen
Journal:  Cancer Ther       Date:  2006

6.  Cytokine immuno-gene therapy for treatment of brain tumors.

Authors:  Terry Lichtor; Roberta P Glick
Journal:  J Neurooncol       Date:  2003-12       Impact factor: 4.130

7.  Lymphokine production by human melanoma tumor-infiltrating lymphocytes.

Authors:  M A Salmeron; T Morita; H Seki; C D Platsoucas; K Itoh
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

8.  Retinoic acid-induced down-regulation of the interleukin-2 promoter via cis-regulatory sequences containing an octamer motif.

Authors:  M P Felli; A Vacca; D Meco; I Screpanti; A R Farina; M Maroder; S Martinotti; E Petrangeli; L Frati; A Gulino
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

9.  Constitutive activation of the interleukin 2 gene in the induction of spontaneous in vitro transformation and tumorigenicity of T cells.

Authors:  M Nagarkatti; M Hassuneh; A Seth; K Manickasundari; P S Nagarkatti
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

10.  MHC antigen expression by melanomas recovered from mice treated with allogeneic mouse fibroblasts genetically modified for interleukin-2 secretion and the expression of melanoma-associated antigens.

Authors:  T S Kim; E P Cohen
Journal:  Cancer Immunol Immunother       Date:  1994-03       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.